Formulary Monographs [MYCOPHENOLATE, 9244]
|
|
MYCOPHENOLATE
|
|
|
|
|
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
Prophylaxis of acute renal, cardiac, or hepatic transplant rejection.
|
|
|
Taste disturbance, gingival hyperplasia anorexia, weight loss, vomiting, abdominal pain, gastro-intestinal inflammation, ulceration, and bleeding. Patients should undergo regular blood counts; if neutropenia develops consideration should be given to interrupting mycophenolate treatment, reducing the dose, or stopping therap y .
|
|
|
Adult: Cardiac transp lantation: 1.5 g twice daily starting within 5
day s of tansp lantation. Renal: 1 g twice daily , to be started within 72 hours of transp lantation. |
|
|
|
|
|
|
|
|
|
|
|
|